1. Home
  2. NYXH vs HIE Comparison

NYXH vs HIE Comparison

Compare NYXH & HIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • HIE
  • Stock Information
  • Founded
  • NYXH 2009
  • HIE 2014
  • Country
  • NYXH Belgium
  • HIE United States
  • Employees
  • NYXH N/A
  • HIE N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • HIE Trusts Except Educational Religious and Charitable
  • Sector
  • NYXH Health Care
  • HIE Finance
  • Exchange
  • NYXH Nasdaq
  • HIE Nasdaq
  • Market Cap
  • NYXH 261.1M
  • HIE 221.9M
  • IPO Year
  • NYXH 2021
  • HIE N/A
  • Fundamental
  • Price
  • NYXH $8.22
  • HIE $12.50
  • Analyst Decision
  • NYXH Strong Buy
  • HIE
  • Analyst Count
  • NYXH 5
  • HIE 0
  • Target Price
  • NYXH $17.00
  • HIE N/A
  • AVG Volume (30 Days)
  • NYXH 26.6K
  • HIE 34.9K
  • Earning Date
  • NYXH 11-06-2024
  • HIE 01-01-0001
  • Dividend Yield
  • NYXH N/A
  • HIE 5.59%
  • EPS Growth
  • NYXH N/A
  • HIE N/A
  • EPS
  • NYXH N/A
  • HIE N/A
  • Revenue
  • NYXH $5,668,079.00
  • HIE N/A
  • Revenue This Year
  • NYXH $37.10
  • HIE N/A
  • Revenue Next Year
  • NYXH $418.12
  • HIE N/A
  • P/E Ratio
  • NYXH N/A
  • HIE N/A
  • Revenue Growth
  • NYXH 32.65
  • HIE N/A
  • 52 Week Low
  • NYXH $4.00
  • HIE $9.50
  • 52 Week High
  • NYXH $20.00
  • HIE $11.00
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 30.23
  • HIE 62.24
  • Support Level
  • NYXH $8.10
  • HIE $12.45
  • Resistance Level
  • NYXH $10.01
  • HIE $12.38
  • Average True Range (ATR)
  • NYXH 0.47
  • HIE 0.13
  • MACD
  • NYXH -0.19
  • HIE 0.02
  • Stochastic Oscillator
  • NYXH 6.28
  • HIE 92.86

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About HIE Miller/Howard High Income Equity Fund of Beneficial Interest

Miller/Howard High Income Equity Fund is a closed-end, diversified management investment company. The fund's primary investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It invests under normal market conditions, a majority of its total assets in dividend or distribution paying equity securities of U.S. companies and non-U.S. companies traded on U.S. exchanges. Its portfolio of investments consists of securities of different sectors such as Natural Gas Transmission, Real Estate Investment Trusts, Petroleum Refining, Oil and Gas Extraction, Electric Services and others.

Share on Social Networks: